In the last trading session, 11.02 million shares of the Qualigen Therapeutics Inc (NASDAQ:QLGN) were traded, and its beta was -0.79. Most recently the company’s share price was $0.11, and it changed around -$0.01 or -7.65% from the last close, which brings the market valuation of the company to $3.03M. QLGN currently trades at a discount to its 52-week high of $0.87, offering almost -690.91% off that amount. The share price’s 52-week low was $0.08, which indicates that the current value has risen by an impressive 27.27% since then. We note from Qualigen Therapeutics Inc’s average daily trading volume that its 10-day average is 15.89 million shares, with the 3-month average coming to 2.56 million.
Qualigen Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended QLGN as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Qualigen Therapeutics Inc is expected to report earnings per share of 0 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Qualigen Therapeutics Inc (NASDAQ:QLGN) trade information
Instantly QLGN has showed a red trend with a performance of -7.65% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.2090 on recent trading dayincreased the stock’s daily price by 47.37%. The company’s shares are currently down -79.60% year-to-date, but still down -38.52% over the last five days. On the other hand, Qualigen Therapeutics Inc (NASDAQ:QLGN) is -35.14% down in the 30-day period. We can see from the shorts that 0.11 million shares have been sold at a short interest cover period of 0.72 day(s).
The company’s sales for the same quarters a year ago were 1.39M and 1.61M respectively.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 71.09%.
QLGN Dividends
Qualigen Therapeutics Inc’s next quarterly earnings report is expected to be released in November.
Qualigen Therapeutics Inc (NASDAQ:QLGN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 5.13% of Qualigen Therapeutics Inc shares, and 1.45% of them are in the hands of institutional investors. The stock currently has a share float of 1.53%.
